Sensitive and frequent identification of high avidity neo-epitope specific CD8+ T cells in immunotherapy-naive ovarian cancer

被引:118
作者
Bobisse, Sara [1 ]
Genolet, Raphael [1 ]
Roberti, Annalisa [2 ]
Tanyi, Janos L. [2 ]
Racle, Julien [1 ,3 ]
Stevenson, Brian J. [3 ]
Iseli, Christian [3 ]
Michel, Alexandra [1 ]
Le Bitoux, Marie-Aude [1 ]
Guillaume, Philippe [1 ]
Schmidt, Julien [1 ]
Bianchi, Valentina [1 ]
Dangaj, Denarda [1 ]
Fenwick, Craig [4 ]
Derre, Laurent [5 ]
Xenarios, Ioannis [3 ]
Michielin, Olivier [1 ,3 ]
Romero, Pedro [1 ]
Monos, Dimitri S. [3 ,6 ]
Zoete, Vincent [1 ,3 ]
Gfeller, David [1 ]
Kandalaft, Lana E. [1 ,2 ]
Coukos, George [1 ]
Harari, Alexandre [1 ]
机构
[1] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Univ Hosp, Dept Oncol, CH-1066 Lausanne, Switzerland
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA
[3] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland
[4] Lausanne Univ Hosp, Dept Med, Div Immunol & Allergy, CH-1066 Lausanne, Switzerland
[5] Lausanne Univ Hosp, Urol Res Unit, CH-1011 Lausanne, Switzerland
[6] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Immunogenet Lab, Philadelphia, PA 19104 USA
来源
NATURE COMMUNICATIONS | 2018年 / 9卷
关键词
TUMOR-INFILTRATING LYMPHOCYTES; MULTIPLE SEQUENCE ALIGNMENT; CHIMERIC ANTIGEN RECEPTOR; METASTATIC MELANOMA; CTLA-4; BLOCKADE; PATIENT; NEOANTIGENS; ASSOCIATION; EXPRESSION; REACTIVITY;
D O I
10.1038/s41467-018-03301-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Immunotherapy directed against private tumor neo-antigens derived from non-synonymous somatic mutations is a promising strategy of personalized cancer immunotherapy. However, feasibility in low mutational load tumor types remains unknown. Comprehensive and deep analysis of circulating and tumor-infiltrating lymphocytes (TILs) for neo-epitope specific CD8(+) T cells has allowed prompt identification of oligoclonal and polyfunctional such cells from most immunotherapy-naive patients with advanced epithelial ovarian cancer studied. Neo-epitope recognition is discordant between circulating T cells and TILs, and is more likely to be found among TILs, which display higher functional avidity and unique TCRs with higher predicted affinity than their blood counterparts. Our results imply that identification of neoepitope specific CD8(+) T cells is achievable even in tumors with relatively low number of somatic mutations, and neo-epitope validation in TILs extends opportunities for mutanomebased personalized immunotherapies to such tumors.
引用
收藏
页数:10
相关论文
共 54 条
  • [21] High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
    Linnemann, Carsten
    van Buuren, Marit M.
    Bies, Laura
    Verdegaal, Els M. E.
    Schotte, Remko
    Calis, Jorg J. A.
    Behjati, Sam
    Velds, Arno
    Hilkmann, Henk
    el Atmioui, Dris
    Visser, Marten
    Stratton, Michael R.
    Haanen, John B. A. G.
    Spits, Hergen
    van der Burg, Sjoerd H.
    Schumacher, Ton N. M.
    [J]. NATURE MEDICINE, 2015, 21 (01) : 81 - 85
  • [22] Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
    Love, Michael I.
    Huber, Wolfgang
    Anders, Simon
    [J]. GENOME BIOLOGY, 2014, 15 (12):
  • [23] Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
    Lu, Yong-Chen
    Yao, Xin
    Li, Yong F.
    El-Gamil, Mona
    Dudley, Mark E.
    Yang, James C.
    Almeida, Jorge R.
    Douek, Daniel C.
    Samuels, Yardena
    Rosenberg, Steven A.
    Robbins, Paul F.
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 190 (12) : 6034 - 6042
  • [24] NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
    Lundegaard, Claus
    Lamberth, Kasper
    Harndahl, Mikkel
    Buus, Soren
    Lund, Ole
    Nielsen, Morten
    [J]. NUCLEIC ACIDS RESEARCH, 2008, 36 : W509 - W512
  • [25] MacKerell AD, 2001, BIOPOLYMERS, V56, P257
  • [26] Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
    Maude, Shannon L.
    Frey, Noelle
    Shaw, Pamela A.
    Aplenc, Richard
    Barrett, David M.
    Bunin, Nancy J.
    Chew, Anne
    Gonzalez, Vanessa E.
    Zheng, Zhaohui
    Lacey, Simon F.
    Mahnke, Yolanda D.
    Melenhorst, Jan J.
    Rheingold, Susan R.
    Shen, Angela
    Teachey, David T.
    Levine, Bruce L.
    June, Carl H.
    Porter, David L.
    Grupp, Stephan A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (16) : 1507 - 1517
  • [27] Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180
  • [28] PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
    Mootha, VK
    Lindgren, CM
    Eriksson, KF
    Subramanian, A
    Sihag, S
    Lehar, J
    Puigserver, P
    Carlsson, E
    Ridderstråle, M
    Laurila, E
    Houstis, N
    Daly, MJ
    Patterson, N
    Mesirov, JP
    Golub, TR
    Tamayo, P
    Spiegelman, B
    Lander, ES
    Hirschhorn, JN
    Altshuler, D
    Groop, LC
    [J]. NATURE GENETICS, 2003, 34 (03) : 267 - 273
  • [29] UCSF chimera - A visualization system for exploratory research and analysis
    Pettersen, EF
    Goddard, TD
    Huang, CC
    Couch, GS
    Greenblatt, DM
    Meng, EC
    Ferrin, TE
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (13) : 1605 - 1612
  • [30] Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
    Prickett, Todd D.
    Crystal, Jessica S.
    Cohen, Cyrille J.
    Pasetto, Anna
    Parkhurst, Maria R.
    Gartner, Jared J.
    Yao, Xin
    Wang, Rong
    Gros, Alena
    Li, Yong F.
    El-Gamil, Mona
    Trebska-McGowan, Kasia
    Rosenberg, Steven A.
    Robbins, Paul F.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (08) : 669 - 678